JUL 13, 2015 11:18 AM PDT

Cheap Vaccine For Cholera Is Successful In Bangladesh

WRITTEN BY: Kara Marker
Cholera is the most prominent diarrheal disease in Bangladesh. Its widespread infection is due to unsanitary conditions because of constant, invasive flooding. Worldwide cholera kills about 110,000 people each year, and medical agencies around the world have been trying to reduce the number of infections for decades (WHO).

Oral rehydration therapy is used to treat cholera patients, relieving dehydrated bodies with fluids packed with nutrients and electrolytes. Oral cholera vaccines are also available. In an article published in The Lancet last week, scientists showed the impact of supplying an entire vulnerable population with a cholera vaccine. The vaccine is called Shanchol, and it works by killing whole cells of cholera bacteria (StopCholera).

Oral cholera vaccines can save lives
In an interview on Friday with The Lancet's Richard Lane, scientist Firdausi Qadri from the International Centre for Diarrhoeal Disease and Research shared her experience with the cholera study in Bangladesh. In addition to flooding, the highly migrating population in Bangladesh is another roadblock for anti-cholera campaigns, Qadri explained. However, the "real-life study" they were able to conduct administering Shanchol to people in Bangladesh showed 53% protection. Qadri emphasized that "the important thing is that protection was sustained for two years in all age groups." The elements of vaccine sustainability and longevity are vital for the success of Shanchol in Bangladesh. It only costs 3.70$ for two doses of the vaccine and does not require a buffer for administration, in comparison to the "Traveler's Vaccine," also known as Dukoral (International Vaccine Institute). Lifestyle habits such as handwashing and maintaining good hygiene surprisingly did not have a significant effect on reducing cases of cholera when compared to vaccine administration.

The National Immunization Program of Bangladesh strives to continue "looking at different strategies for using the vaccine in Bangladesh." Among these strategies include enabling Shanchol to be locally produced, increasing its ability to be produced at an even lower cost.

Currently in Bangladesh, 25 million people out of the 160 million total population are at risk for cholera. Hopefully with the continued production, distribution, and usage of the Shanchol vaccine, these numbers of vulnerable people will decrease to the point where cholera is no longer endemic in Bangladesh.

Source: The Lancet

Epidemiologist Dr. David Boulware discusses in more detail cholera virulence and the cholera pandemic:

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 24, 2021
Clinical & Molecular DX
A New Chapter in Metastatic Breast Cancer Biomarkers
AUG 24, 2021
A New Chapter in Metastatic Breast Cancer Biomarkers
For patients diagnosed with metastatic breast cancer, it’s often not the primary tumor that has fatal consequences ...
AUG 26, 2021
Plants & Animals
Flavonoid-rich Foods Help Regulate Blood Pressure
AUG 26, 2021
Flavonoid-rich Foods Help Regulate Blood Pressure
Flavonoid-rich foods may have a positive effect on blood pressure levels, though according to new research, the secret t ...
SEP 02, 2021
Cancer
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
SEP 02, 2021
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
High cholesterol is associated with an increased risk of several types of cancer, and cancer patients with high choleste ...
SEP 06, 2021
Microbiology
Imbokodo Trial Shows HIV Vaccine Candidate Isn't Effective Enough
SEP 06, 2021
Imbokodo Trial Shows HIV Vaccine Candidate Isn't Effective Enough
HIV vaccines have remained elusive in part because the virus has a powerful ability to mutate, and there are so many str ...
SEP 10, 2021
Health & Medicine
Intervention for Endocarditis- What Kind of Valve is Best?
SEP 10, 2021
Intervention for Endocarditis- What Kind of Valve is Best?
  Infective endocarditis is caused when a bacterium such as staphylococcus enters the bloodstream and infects heart ...
SEP 13, 2021
Health & Medicine
How Farming Shaped the Immune System
SEP 13, 2021
How Farming Shaped the Immune System
In today's society, a rural upbringing is associated with a healthier immune system less prone to allergies and auto ...
Loading Comments...